뉴스벤징가
Penny Stock Neumora Therapeutics Cuts Workforce After Depression Trials Fail
· 발표
기사 요약
Neumora Therapeutics ends navacaprant development after Phase 3 depression trial setbacks, cuts workforce by 35%.
기사 원문에서 발췌했어요.Neumora Therapeutics ends navacaprant development after Phase 3 depression trial setbacks, cuts workforce by 35%.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…